Bronchopulmonary dysplasia · promoting growth and development in very low birth weight infants receiving human milk
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Rate of weight gain (g/kg/day) · promoting growth and development in very low birth weight infants receiving human milk
1 finding from 1 review
Linear growth (cm/week) · promoting growth and development in very low birth weight infants receiving human milk
1 finding from 1 review
Growth velocity, head circumference, mm/d, end of intervention · promoting growth and development in very low birth weight infants receiving human milk
1 finding from 1 review
All‐cause mortality · promoting growth and development in very low birth weight infants receiving human milk
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
NEC ≥ stage II · promoting growth and development in very low birth weight infants receiving human milk
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Culture‐proven late‐onset sepsis · promoting growth and development in very low birth weight infants receiving human milk
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Retinopathy of prematurity · promoting growth and development in very low birth weight infants receiving human milk
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Bronchopulmonary dysplasia · promoting growth and development in very low birth weight infants receiving human milk
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Progression‐free survival · women with advanced EOC after primary IDS
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Overall survival: Median length of · women with advanced EOC after primary IDS
It is very uncertain whether large‐volume residual disease (LVRD) > 1 cm changes overall survival: Median length of compared with small‐volume residual disease (SVRD) < 1 cm (very low certainty).
1 finding from 1 review
Progression‐free survival · women with advanced EOC after primary IDS
It is very uncertain whether large‐volume residual disease (LVRD) > 1 cm changes progression‐free survival: Median length of compared with small‐volume residual disease (SVRD) < 1 cm (very low certainty).
1 finding from 1 review
Overall survival: Median length of · women with advanced ovarian cancer after PDS
Large‐volume residual disease (LVRD) > 1 cm probably leads to higher overall survival: Median length of compared with no macroscopic residual disease (NMRD) (moderate certainty).
1 finding from 1 review
Progression‐free survival · women with advanced ovarian cancer after PDS
Large‐volume residual disease (LVRD) > 1 cm probably leads to higher progression‐free survival: Median length of compared with no macroscopic residual disease (NMRD) (moderate certainty).
1 finding from 1 review
Overall survival: Median length of · women with advanced EOC after PDS
Large‐volume residual disease (LVRD) > 1 cm probably leads to higher overall survival: Median length of compared with small‐volume residual disease (SVRD) < 1 cm (moderate certainty).
1 finding from 1 review
Progression‐free survival · women with advanced EOC after PDS
Large‐volume residual disease (LVRD) > 1 cm probably leads to higher progression‐free survival: Median length of compared with small‐volume residual disease (SVRD) < 1 cm (moderate certainty).
1 finding from 1 review
Overall survival: Median length of · women with advanced EOC after primary IDS
It is very uncertain whether large‐volume residual disease (LVRD) > 1 cm changes overall survival: Median length of compared with no macroscopic residual disease (NMRD) (very low certainty).
1 finding from 1 review
Rate of weight gain (g/kg/day) · promoting growth and development in very low birth weight infants receiving human milk
1 finding from 1 review
End of intervention: rate of gain in length (cm/week) · promoting growth and development in very low birth weight infants receiving human milk
1 finding from 1 review
Growth velocity, head circumference, mm/d, end of intervention · promoting growth and development in very low birth weight infants receiving human milk
1 finding from 1 review